India’s pharmaceutical market demonstrated robust growth, climbing 8.1% in August, fueled by chronic treatments like cardiac and anti-diabetic drugs. Respiratory and cancer medications also saw strong demand. GLP-1 therapies experienced a remarkable 97% surge, significantly boosting anti-diabetic sales.